Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam, Amer Assal, Eszter Lázár‐Molnár, et al.
Trends in Molecular Medicine (2014) Vol. 21, Iss. 1, pp. 24-33
Open Access | Times Cited: 746

Showing 26-50 of 746 citing articles:

RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
Jared Adolf‐Bryfogle, Oleksandr Kalyuzhniy, Michael Kubitz, et al.
PLoS Computational Biology (2018) Vol. 14, Iss. 4, pp. e1006112-e1006112
Open Access | Times Cited: 173
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 167
Angiosarcoma: a review of diagnosis and current treatment.
Jun Cao, Jiale Wang, Chiyu He, et al.
PubMed (2019) Vol. 9, Iss. 11, pp. 2303-2313
Closed Access | Times Cited: 163
Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment
Xingpei Hao, Steven D. Billings, Fangbai Wu, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1752-1752
Open Access | Times Cited: 159
Nanomedicine-based tumor photothermal therapy synergized immunotherapy
Tongyi Shang, Xinying Yu, Shisong Han, et al.
Biomaterials Science (2020) Vol. 8, Iss. 19, pp. 5241-5259
Closed Access | Times Cited: 152
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment
Moataz Reda, Worapol Ngamcherdtrakul, Molly A. Nelson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 125
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani, James A. Holden, Wenyi Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 114
Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy
Wei Xiong, Lin Qi, Ning Jiang, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 7, pp. 8026-8041
Closed Access | Times Cited: 108
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 99
Recent advances in long-acting drug delivery systems for anticancer drug
Catarina Pacheco, Ana Baião, Tao Ding, et al.
Advanced Drug Delivery Reviews (2023) Vol. 194, pp. 114724-114724
Open Access | Times Cited: 97
Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy
Yu Liu, Zaigang Zhou, Ji-Ting Hou, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Open Access | Times Cited: 93
Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
Pratibha Pandey, Fahad Khan, Huda A. Qari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 335-335
Open Access | Times Cited: 76
A comprehensive review of SHP2 and its role in cancer
Moges Dessale Asmamaw, Xiaojing Shi, Lirong Zhang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 729-753
Closed Access | Times Cited: 74
Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
Marta Warszyńska, Paweł Repetowski, J. Dąbrowski
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215350-215350
Open Access | Times Cited: 59
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 57
Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation
Wei Xiang, Hongwei Lv, Fuxue Xing, et al.
Science Advances (2023) Vol. 9, Iss. 49
Open Access | Times Cited: 52
The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer
Tarek Taifour, Sherif Samer Attalla, Dongmei Zuo, et al.
Immunity (2023) Vol. 56, Iss. 12, pp. 2755-2772.e8
Open Access | Times Cited: 49
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
Alex G. Hamilton, Kelsey L. Swingle, Ryann A. Joseph, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Open Access | Times Cited: 45
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, et al.
Cancer Biology and Medicine (2024), pp. 1-11
Open Access | Times Cited: 20
New immunotherapies targeting the PD-1 pathway
Jordan M. Chinai, Murali Janakiram, Fuxiang Chen, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 9, pp. 587-595
Open Access | Times Cited: 174
PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
Jacqueline Fontugne, Jérémy Augustin, Anaïs Pujals, et al.
Oncotarget (2017) Vol. 8, Iss. 15, pp. 24644-24651
Open Access | Times Cited: 164
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
Frank P. Vendetti, Pooja Karukonda, David A. Clump, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 9, pp. 3926-3940
Open Access | Times Cited: 160
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
Powell Perng, Michael Lim
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 158
Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes
Arutselvan Natarajan, Aaron T. Mayer, Lingyun Xu, et al.
Bioconjugate Chemistry (2015) Vol. 26, Iss. 10, pp. 2062-2069
Closed Access | Times Cited: 156

Scroll to top